James Hardie Industries (JHX) Company Report

Analyst Coverage

Research analysts who have asked questions during James Hardie Industries earnings calls.

Keith Chau

MST Marquee

8 questions for JHX

Also covers: AMCR

Keith Hughes

Truist Financial Corporation

7 questions for JHX

Also covers: AMRZ, AWI, BLD +21 more

Lee Power

UBS

5 questions for JHX

Peter Steyn

Macquarie Group

5 questions for JHX

Ryan Merkel

William Blair & Company

5 questions for JHX

Also covers: AAON, AYI, AZEK +15 more

Brook Campbell-Crawford

Barrenjoey

4 questions for JHX

Also covers: AMCR

Philip Ng

Jefferies

4 questions for JHX

Also covers: AWI, AZEK, BALL +26 more

Andrew Scott

Morgan Stanley

3 questions for JHX

Also covers: CODA, SURG, VBNK

Daniel Kang

CLSA

3 questions for JHX

Also covers: AMCR

Harry Saunders

E&P Financial Group

3 questions for JHX

Matthew McKellar

RBC Capital Markets

3 questions for JHX

Also covers: CLW, IP, LPX +8 more

Trevor Allinson

Wolfe Research, LLC

3 questions for JHX

Also covers: AMWD, AZEK, BECN +18 more

Alistair Harvey

JPMorgan Chase & Co.

2 questions for JHX

Also covers: NEM

Matthew Bouley

Barclays

2 questions for JHX

Also covers: CNM, DHI, FBIN +10 more

Peterson

Macquarie

2 questions for JHX

Sam Seow

Citi

2 questions for JHX

Shaurya Visen

Bank of America

2 questions for JHX

Tim Weiss

Baird

2 questions for JHX

Tim Wojs

Robert W. Baird & Co. Incorporated

2 questions for JHX

Also covers: AAON, ALLE, AYI +6 more

Adam Baumgarden

Vertical Research Partners

1 question for JHX

Adam Baumgarten

Zelman & Associates

1 question for JHX

Also covers: AMWD, AWI, AZEK +12 more

Kai Erman

Jefferies

1 question for JHX

Niraj-Samip Shah

Goldman Sachs

1 question for JHX

Also covers: AMCR

Phil Ng

Jefferies Financial Group Inc.

1 question for JHX

Also covers: BALL, FBIN, IP +2 more

Samuel Seow

Citigroup

1 question for JHX

Also covers: AMCR

Timothy Wojs

Robert W. Baird & Co.

1 question for JHX

Also covers: AAON, ALLE, AMWD +13 more

Trevor Allenson

Wolfe Research

1 question for JHX

Will Wilson

UBS

1 question for JHX

Latest news

Recent press releases and 8-K filings for JHX.

James Hardie Industries plc Reports Director Share Sale, Substantial Shareholder Change, and Equity Issuances

JHX

M&A

Executive Compensation

Substantial Holding Change

Director Jesse Singh indirectly disposed of 400,000 Ordinary Shares for USD $10,447,120 on February 12, 2026, through an on-market sale by The Jesse G. Singh Revocable Trust.
FMR LLC became a substantial holder, crossing the 3% threshold with 3.0323% of total voting rights on February 11, 2026.
James Hardie Industries plc issued a total of 52,144 Ordinary Shares (JHXAM) between February 9 and February 13, 2026, as part of the settlement of AZEK equity awards following the merger with The AZEK Company Inc. on July 1, 2025.
The company granted 85,742 Restricted Stock Units (JHXAK) to Jonathan Skelly on February 9, 2026, under an employee incentive scheme.

Feb 20, 2026, 12:54 AM

6-K

James Hardie Reports Q3 FY26 Results and Updates FY26 Guidance

JHX

Earnings

M&A

Guidance Update

James Hardie reported Q3 FY26 Net Sales of $1.2 billion, an increase of +30%, with Adjusted EBITDA of $330 million, up +26%, primarily driven by the AZEK acquisition. However, Adjusted Diluted EPS decreased by (31%) to $0.24.
The company is ahead of schedule on the integration of AZEK and has surpassed its FY26 cost synergy goal, reaffirming confidence in achieving its $125 million cost synergy target.
James Hardie updated its FY26 financial guidance, with Consolidated Adjusted EBITDA now projected between $1.232 billion and $1.263 billion.
The company's net leverage ratio was ~3.0x at December 31, 2025, with a target to reach ≤ 2.0x by Q3 FY28 through strong free cash flow generation.

Feb 10, 2026, 11:06 PM

6-K

James Hardie Industries Reports Q3 2026 Results and Raises FY 2026 Guidance

JHX

Earnings

Guidance Update

M&A

James Hardie Industries reported Q3 2026 total net sales of $1.24 billion, a 30% increase (including $275 million from acquired AZEK sales), with organic sales up 1%, and adjusted EBITDA of $330 million. Adjusted diluted earnings per share was $0.24.
The company raised its full year 2026 adjusted EBITDA guidance to $1.232 billion-$1.263 billion.
Strategic actions include the closure of two older, less efficient plants in mid-January, expected to generate $25 million in annual cost savings starting in Q1 FY 2027.
James Hardie is on track to achieve its $125 million cost synergy target and anticipates delivering $125 million in annualized commercial synergy run rate exiting FY 2027 from the AZEK combination.
For FY 2027, the company's goal is to return to both organic revenue growth and adjusted EBITDA margin expansion.

Feb 10, 2026, 10:00 PM

Transcript

James Hardie Industries Reports Strong Q3 2026 Results and Raises Full Year Guidance

JHX

Earnings

Guidance Update

M&A

James Hardie Industries reported Q3 2026 total net sales of $1.24 billion, a 30% increase, with 1% organic sales growth and adjusted EBITDA of $330 million.
The company raised its full year 2026 adjusted EBITDA guidance to a range of $1.232 billion-$1.263 billion.
Strategic actions, including the closure of two plants, are expected to generate $25 million in annual cost savings starting Q1 FY 2027, incremental to AZEK cost synergies.
James Hardie is confident in achieving $125 million in cost synergies and $125 million in annualized commercial synergy run rate exiting FY 2027, and expects to return to organic revenue growth and adjusted EBITDA margin expansion in FY 2027.

Feb 10, 2026, 10:00 PM

Transcript

James Hardie Industries Reports Q3 2026 Results and Updates Full-Year Guidance

JHX

Earnings

Guidance Update

M&A

James Hardie Industries reported Q3 2026 total net sales of $1.24 billion, a 30% increase including $275 million from the AZEK acquisition, with organic sales up 1%, and adjusted EBITDA of $330 million.
The company updated its full-year 2026 guidance, raising the ranges for Siding and Trim net sales to $2.953 billion - $2.998 billion and Adjusted EBITDA to $939 million - $962 million, and for total company Adjusted EBITDA to $1.232 billion - $1.263 billion.
Strategic actions include the closure of two less efficient plants on January 15th, projected to generate $25 million in annual cost savings starting Q1 FY 2027, and continued integration of the AZEK acquisition to drive commercial synergies and long-term growth.
Management expects to return to margin expansion in FY 2027 and aims for 4% PDG (Price/Volume/Mix) growth with synergies on top, while committing to reduce net leverage below 2x within two years post-AZEK acquisition.

Feb 10, 2026, 10:00 PM

Transcript

James Hardie Industries plc to Optimize Manufacturing Footprint and Reaffirms FY26 Guidance

JHX

Guidance Update

Layoffs

James Hardie Industries plc announced plans to optimize its manufacturing footprint by closing facilities in Fontana, California, and Summerville, South Carolina within the next 60 days.
This optimization is expected to generate annualized cost savings of approximately $25 million beginning in the first quarter of fiscal year 2027.
The company anticipates one-time pre-tax charges of approximately $40 million to $44 million, primarily in the fourth quarter of fiscal year 2026.
James Hardie reaffirmed its guidance for the third quarter and full fiscal year 2026.

Jan 15, 2026, 9:44 PM

6-K

James Hardie Industries PLC Issues Ordinary Shares Related to Merger and Employee Incentive Plan

JHX

M&A

Executive Compensation

James Hardie Industries PLC issued a total of 276,796 unquoted ordinary shares in December 2025.
On December 16, 2025, 212,314 ordinary shares were issued at $0.6933 USD per share, and on December 15, 2025, 48,957 ordinary shares were issued at $0.6924 USD per share, both related to the merger with The AZEK Company Inc..
An additional 15,525 ordinary shares were issued on December 15, 2025, under the James Hardie 2020 Non-Executive Director Equity Plan.
Several directors, including Persio V. Lisboa, Nigel Stein, Suzanne B. Rowland, Renee Peterson, John C Pfeifer, Howard Heckes, and Jesse Singh, acquired ordinary shares on December 15, 2025, as part of the employee incentive scheme.

Dec 23, 2025, 5:29 PM

6-K

James Hardie Industries Faces Class Action Lawsuit

JHX

Legal Proceedings

Demand Weakening

A class action lawsuit has been filed against James Hardie Industries plc (JHX), with a Lead Plaintiff Deadline of December 23, 2025.
The lawsuit alleges that James Hardie executives made materially false and misleading statements about the health of its North America Fiber Cement segment, specifically concealing aggressive inventory destocking by distributors.
The company's stock subsequently crashed over 34% on August 20, 2025, following the disclosure of a 12% decline in North America sales, which the lawsuit claims was due to the customer weakness allegedly concealed.
The class period for investors who purchased JHX stock and suffered substantial losses is May 20, 2025, through August 18, 2025.

Dec 15, 2025, 6:00 PM

Press Release

James Hardie Industries Faces Securities Class Action Lawsuit

JHX

Legal Proceedings

Demand Weakening

Investors in James Hardie Industries plc (JHX) are reminded that the Lead Plaintiff Deadline in a securities class action lawsuit is December 23, 2025.
The lawsuit alleges that James Hardie and its executives made materially false and misleading statements about the health of its crucial North America Fiber Cement segment, specifically concealing aggressive distributor inventory destocking.
The company's stock crashed over 34% on August 20, 2025, after it allegedly disclosed a 12% decline in North America sales due to customer destocking.
The Class Period for the lawsuit is May 20, 2025 – August 18, 2025, covering investors who purchased JHX stock during this time and suffered substantial losses.

Dec 13, 2025, 9:15 PM

Press Release

James Hardie Industries Faces Securities Class Action Lawsuit

JHX

Legal Proceedings

Demand Weakening

The Lead Plaintiff Deadline for the securities class action lawsuit against James Hardie Industries (JHX) is December 23, 2025.
The lawsuit alleges that James Hardie executives made materially false and misleading statements about the health of its North America Fiber Cement segment, specifically concealing distributor inventory destocking.
JHX stock crashed over 34% on August 20, 2025, after the company disclosed a 12% decline in North America sales due to customer destocking.
Investors who purchased James Hardie stock between May 20, 2025, and August 18, 2025, and suffered substantial losses are encouraged to contact Hagens Berman.